Michael Koslowski

Humboldt-Universität zu Berlin — Germany

Psychology · Social Sciences

11h-index1.6kcitations29works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Psychedelics and Drug Studies(15), Chemical synthesis and alkaloids(9), Neurotransmitter Receptor Influence on Behavior(7), Schizophrenia research and treatment(6), Functional Brain Connectivity Studies(5)

Publications29 total

High Society? Die Bandbreite psychoaktiver Substanzen in unserer Gesellschaft
Nervenheilkunde·2026
Psychedelika und Entaktogene: Neue Hoffnung für therapieresistente Störungen?
Nervenheilkunde·2026
Predictors of therapeutic response to psychedelic-assisted therapy: A systematic review
Journal of Psychopharmacology·2025· 1 citedOpen Access
Exploring the biological function of dreaming: lessons learned from recruitment challenges in a pilot study with PCA stroke patients
Frontiers in Sleep·2025Open Access
A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research
Psychedelic Medicine·2025· 4 citedOpen Access
Therapie mit Psychedelika
Die Psychotherapie·2024Open Access
Ethische Aspekte der Therapie mit Psychedelika
Die Psychotherapie·2024· 4 citedOpen Access
Guiding Through Challenging Psychedelic Experiences and “Bad Trips”
Current topics in behavioral neurosciences·2024· 5 cited
Neural effects of psilocybin-treatment in patients with treatment-resistant depression
Neuroscience Applied·2024Open Access
Psychedelikagestützte Psychotherapie in der Behandlung depressiver Störungen
Nervenheilkunde·2023
Converging theories on dreaming: Between Freud, predictive processing, and psychedelic research
Frontiers in Human Neuroscience·2023· 11 citedOpen Access
Processing Individually Distinctive Schematic-Faces Supports Proto-Arithmetical Counting in the Young Domestic Chicken
Animals·2022· 4 citedOpen Access
Cannabis Use, Use Motives and Cannabis Use Disorder Among Berlin College Students
Journal of Drug Issues·2022· 6 cited
Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) – Rationale and study design
Neuroscience Applied·2022· 34 citedOpen Access
P.0421 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) – study design, rationale and current status
European Neuropsychopharmacology·2021
Novel Treatment Approaches for Substance Use Disorders: Therapeutic Use of Psychedelics and the Role of Psychotherapy
Current Addiction Reports·2021· 36 citedOpen Access
Therapie mit Psychedelika - die Rolle der Psychotherapie
NeuroTransmitter·2020· 2 cited
Using routine MRI data of depressed patients to predict individual responses to electroconvulsive therapy
Experimental Neurology·2020· 17 cited
LSD in der Therapie psychischer Erkrankungen
InFo Neurologie + Psychiatrie·2020
Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance
Frontiers in Psychiatry·2020· 173 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Florian Schlagenhauf(9), Andreas Heinz(8), Felix Betzler(8), Georg Juckel(7), Gerhard Gründer(7), Brian Knutson(6), Jana Wrase(6), Max Wolff(5), Lea J. Mertens(5), Jürgen Gallinat(4), Henrik Jungaberle(4), Werner Strik(4), Druck Reinhardt Druck Basel(4), Torsten Wüstenberg(3), Thorsten Kienast(3), Ricarda Evens(3), Eva Friedel(3), Henning Witthaus(3), Seza Özgürdal(3), Yehonala Gudlowski(3)